• Protocol A2581078 A randomized, multi-center, parallel group, double blind study of the efficacy and safety of atorvastatin 80 mg plus an acethylcholinesterase inhibitor versus an acetylcholinesterase inhibitor alone in the treatment of mild to moderate Alzheimer’s disease.
  • Protocol BI 1198.52 A Phase II Double Blind, Randomized, Dose Ranging, Placebo Controlled Multi-center, Safety and Efficacy Evaluation of three doses of NS 2330 in Patients with Mild to Moderate Dementia of the Alzheimer’s Type.